Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM
- PMID: 21876539
- PMCID: PMC3482684
- DOI: 10.1038/mp.2011.101
Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM
Abstract
Coffee consumption is a model for addictive behavior. We performed a meta-analysis of genome-wide association studies (GWASs) on coffee intake from 8 Caucasian cohorts (N=18 176) and sought replication of our top findings in a further 7929 individuals. We also performed a gene expression analysis treating different cell lines with caffeine. Genome-wide significant association was observed for two single-nucleotide polymorphisms (SNPs) in the 15q24 region. The two SNPs rs2470893 and rs2472297 (P-values=1.6 × 10(-11) and 2.7 × 10(-11)), which were also in strong linkage disequilibrium (r(2)=0.7) with each other, lie in the 23-kb long commonly shared 5' flanking region between CYP1A1 and CYP1A2 genes. CYP1A1 was found to be downregulated in lymphoblastoid cell lines treated with caffeine. CYP1A1 is known to metabolize polycyclic aromatic hydrocarbons, which are important constituents of coffee, whereas CYP1A2 is involved in the primary metabolism of caffeine. Significant evidence of association was also detected at rs382140 (P-value=3.9 × 10(-09)) near NRCAM-a gene implicated in vulnerability to addiction, and at another independent hit rs6495122 (P-value=7.1 × 10(-09))-an SNP associated with blood pressure-in the 15q24 region near the gene ULK3, in the meta-analysis of discovery and replication cohorts. Our results from GWASs and expression analysis also strongly implicate CAB39L in coffee drinking. Pathway analysis of differentially expressed genes revealed significantly enriched ubiquitin proteasome (P-value=2.2 × 10(-05)) and Parkinson's disease pathways (P-value=3.6 × 10(-05)).
Figures
References
-
- Ruusunen A, Lehto SM, Tolmunen T, Mursu J, Kaplan GA, Voutilainen S. Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Public Health Nutr. 2010;13:1215–1220. - PubMed
-
- Sugiyama K, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Ohmori-Matsuda K, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140:1007–1013. - PubMed
-
- Gongora-Alfaro JL. [Caffeine as a preventive drug for Parkinson's disease: epidemiologic evidence and experimental support] La cafeina como un farmaco preventivo de la enfermedad de Parkinson: evidencias epidemiologicas y sustrato experimental. Rev Neurol. 2010;50:221–229. - PubMed
-
- van Dieren S, Uiterwaal CS, van der Schouw YT, van der AD, Boer JM, Spijkerman A, et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009;52:2561–2569. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA007535/AA/NIAAA NIH HHS/United States
- R01 MH066206/MH/NIMH NIH HHS/United States
- AA13320/AA/NIAAA NIH HHS/United States
- BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- R01 AA013321/AA/NIAAA NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- AA14041/AA/NIAAA NIH HHS/United States
- SRF/01/010/DH_/Department of Health/United Kingdom
- AA13326/AA/NIAAA NIH HHS/United States
- R01 AA013320/AA/NIAAA NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- AA13321/AA/NIAAA NIH HHS/United States
- AA10248/AA/NIAAA NIH HHS/United States
- R01 AA013326/AA/NIAAA NIH HHS/United States
- MH66206/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
